Results · Apr-Jun 2026
Novartis India Q1 FY27 results
Sales grew 19% to ₹104 crore from ₹87.6 crore in Apr-Jun 2025.
Operating profit grew 28% to ₹34.9 crore, an operating margin of 33.6% (up 2.5 points from a year ago).
Net profit grew 17% to ₹32.2 crore from ₹27.6 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +15%, net profit +28%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 103.8 | 87.6 | +19% |
| Operating profit (EBITDA) | 34.9 | 27.2 | +28% |
| Operating margin | 33.6% | 31.1% | +2.5 pts |
| Net profit | 32.2 | 27.6 | +17% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.